Energy Stocks to Watch; (OTCBB: AAPH), (NYSE:BP), (NASDAQ: ATPG), (NYSE: DVN)

Devon Energy Corporation (NYSE: DVN) trading at $67.97, up $ 2.04 (3.09%)

Visit this company: www.aaphreport.com
Point Roberts WA - November 3, 2010 (Investorideas.com Energy Newswire) � www.Investorideas.com reports on energy stocks trading for November 3rd. Oil is trading at $84.16 +0.26 +0.31%.

Energy Stocks Trading November 3, 2010

• ATP Oil & Gas (NasdaqGS: ATPG) trading at $14.20, down 0.16 (1.11%)
• American Petro-Hunter, Inc. (OTC.BB: AAPH) trading at $0.32
• Anadarko Petroleum Corporation (NYSE: APC) trading at $ 62.84, down 0.98 (1.54%)
• BP (NYSE: BP) trading at $42.40, up 0.98 (2.37%)
• Chevron Corporation (NYSE: CVX) trading up at $82.47, up 0.32 (0.39%)
• Devon Energy Corporation (NYSE: DVN) trading at $67.97, up $ 2.04 (3.09%)
• Exxon Mobil Corporation Common (NYSE: XOM) trading at $67.93, up 0.09 (0.13%)

Recent Oil and Gas Stocks News:
American Petro-Hunter, Inc. (OTC.BB: AAPH)
Interview with C.E.O. of Oil and Gas Company, American Petro-Hunter (OTCBB: AAPH)
"It Is My Opinion That the Woodford Is a 'Mini-Bakken' and Can Possibly Be One of the Biggest Oil Plays in Oklahoma History" -- Robert McIntosh, President & C.E.O.
Full news: http://finance.yahoo.com/news/Interview-With-CEO-of-Oil-and-iw-449018127.html?x=0&.v=1
ATP Oil & Gas (NasdaqGS: ATPG)
The Big Money Says to Buy ATP Oil & Gas
News link: http://www.fool.com/investing/general/2010/11/03/the-big-money-says-to-buy-atp-oil-gas.aspx
Devon Energy Corporation (NYSE: DVN)
Devon Energy 3Q profit jumps on asset sales
News: http://finance.yahoo.com/news/Devon-Energy-3Q-profit-jumps-apf-1538554895.html?x=0&.v=1
Market Summary

• Dow 11,152.70 -36.02 -0.32%
• Nasdaq 2,520.82 -12.70 -0.50%
• S&P 500 1,188.56 -5.01 -0.42%
• 10 Yr Bond (%) 2.5410% -0.0530
• Oil 84.16 +0.26 +0.31%

Research more energy stocks:
The oil and gas stocks directory lists publicly traded stocks from multiple global stock exchanges including TSX, ASX, OTC, NASDAQ and NYSE.
http://www.investorideas.com/OGSN/Stock_List.asp
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the hunt for domestic petroleum assets. www.americanpetrohunter.com
Company Research
http://www.aaphreport.com/
Visit the AAPH showcase profile at Investorideas.com
http://www.investorideas.com/CO/AAPH/
Request News and Info on AAPH
http://www.investorideas.com/Resources/Newsletter.asp
Disclosure, Disclaimer/ AAPH is a paid for advertising client on Investorideas.com - see below.
Contact American Petro-Hunter:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.

Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp

Disclaimer/ Disclosure: The following news is paid for and /or published as information only for our readers. American Petro-hunter Inc. (AAPH.OB) one month showcase energy stock on Investorideas.com and all related energy portals and blogs (twenty thousand per month)
Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal .This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
For Additional Information about Investorideas.com energy portals: 800-665-0411 or cvanzant@investorideas.com

More Info:

Published at www.Investorideas.com - Global research by sectors

If you have any questions regarding information in this press release please contact the company listed in the press release.

 NASDAQ Biotech/Pharma Market Leaders; (NASDAQ:BPAX), (NASDAQ:AMGN), (NASDAQ:LIFE) Stocks to Follow for Wednesday

Visit this company: www.biosantepharma.com
Point Roberts, WA - November 3, 2010 (Investorideas.com Newswire and www.biotechindustrystocks.com) - InvestorIdeas.com, a leader in sector research tools for investors, features a Biotech /Pharma Sector Snapshot featuring some of the NASDAQ�s Actively traded market leaders for today.

Biotech /Pharma Sector Trading Snapshot: (as of time of release November 3rd)

• BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) trading at $1.52, up 0.02 (1.33%)
• Amgen Inc. (NASDAQ:AMGN), trading at $57.40, up .04 (0.07%)
• Life Technologies Corporation (NASDAQ:LIFE) trading at $ 50.71, up 0.22 (0.44%)

Market Summary:

• Dow 11,211.88 +23.16 +0.21%
• NASDAQ 2,534.96 +1.44 +0.06%
• S&P 500 1,195.23 +1.66 +0.14%
• 10 Yr Bond (%) 2.5490% -0.0450
• Oil 84.42 +0.52 +0.62%
• Gold 1,353.00 -3.40 -0.25%

Biotech/Pharma Stocks Recent News;
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) Reports Positive LibiGel� Data Monitoring Committee Recommendation
No safety issues observed, study to continue as per protocol without modifications
LINCOLNSHIRE, Ill. - (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that the Phase III LibiGel (testosterone gel) cardiovascular and breast cancer safety study will continue without modifications and will continue to enroll new subjects as a result of the fourth unblinded review of adverse events and the first unblinded statistical analysis for sample-size determination by its independent Data Monitoring Committee (DMC). The review and statistical analysis were based on 2,500 subjects who have been enrolled in the study. LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is currently no FDA approved product.
Full news: http://www.investorideas.com/CO/BPAX/news/10252.asp
More news - Visit the BPAX showcase profile at Investorideas.com
http://www.investorideas.com/CO/BPAX/
Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com
Life Technologies Corporation (NASDAQ:LIFE) News:
Life Technologies Launches New SOLiD Sequencer to Drive Advances in Cancer Biology and Genetic Disease Research
"Life Technologies Corporation a provider of innovative life science solutions, today announced the launch of the 5500xl SOLiD™ Sequencer, a new instrument designed to deliver the industry's fastest and most accurate genomic data for cancer biology and genetic disease research.
Developed and manufactured with long-standing partner Hitachi High-Technologies, the 5500xl delivers on the promise of the SOLiD 4hq, which was first announced in January. Initial shipments of the 5500xl are planned for December 2010."
Full Article: http://finance.yahoo.com/news/Life-Technologies-Launches-bw-2424991704.html?x=0&.v=1
About Life Technologies Corporation (NASDAQ:LIFE)
Life Technologies Corporation (NASDAQ:LIFE - News) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of $3.3 billion in 2009, employs approximately 9,000 people, has a presence in approximately 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc., and manufactures both in-vitro diagnostic products and research use only-labeled products. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com.
Research other biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
More info on BPAX:
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) Investor Fact Sheet update and News:
Full Media Kit at: http://www.biosantepharma.com/downloads/BioSante-Fact-Sheet.pdf
Financial Highlights

• At September 30, 2010, BioSante had approximately $36M in cash
• Monthly burn rate of approximately $3.5M

Investment Highlights

• Financial resources to implement plan
• Late stage pharmaceutical product portfolio with significant growth potential
• LibiGel in three ongoing Phase III safety and efficacy clinical studies
• Elestrin is FDA approved and marketed in the U.S.
• Proprietary cancer vaccines in Phase II clinical trials
• Focused growth strategy
• Management's proven ability to gain FDA approval, implement plans and increase stockholder value

About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing covering over thirty industry sectors and global markets including China, India, the Middle East and Australia.

Sign up for free stock alerts on biotech stocks and other leading sectors!
http://www.investorideas.com/Resources/Newsletter.asp

About our Biotech investor portal:
www.BiotechIndustryStocks.com is a global meeting place for investors and industry following the biotech and pharma sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.
Disclaimer/disclosure : The following news is sponsored for by showcase stocks BPAX (three thousand per month BPAX) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal. This site is currently compensated by featured companies, news submissions and online advertising.
More info:
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com

More Info:

Published at www.Investorideas.com - Global research by sectors

If you have any questions regarding information in this press release please contact the company listed in the press release.

Interview With C.E.O. of Oil and Gas Company, American Petro-Hunter (OTCBB: AAPH)

Interview With C.E.O. of Oil and Gas Company, American Petro-Hunter (OTCBB: AAPH)

 POINT ROBERTS, WA and SCOTTSDALE, AZ - November 3, 2010 (Investorideas.com energy newswire) - www.InvestorIdeas.com announces a Q&A Interview with Robert McIntosh, President & C.E.O. of oil and gas company, American Petro-Hunter, Inc. (OTC.BB:AAPH).

Full Interview:
http://www.investorideas.com/CO/AAPH/news/11021.asp

In the recent Cohen Report, the company has a price target of $1.02. Is this based on oil prices staying the current range? And what other factors can change that target price either to the upside or downside?
A: Robert McIntosh, President & C.E.O.
The research report updates the recent development and progress of the Company's oil and gas production projects in Oklahoma and Kansas and concluded with a price target of $1.02 per share. The Grass Roots Research report states that American Petro-Hunter is "a lucrative investment opportunity in the oil and gas E&P space and provides an upside potential of 191.3% in the short and long term."
We did all our pro forma on oil at $70 so with it today at $80 we have a built in cushion for a decrease. Of course, risk in the energy sector is complicated and dependent on many factors such as US demand but we are in the heartland of Kansas and Oklahoma. Even if oil declines to $50 per barrel we will make money for our shareholders.
Q: InvestorIdeas.com
What is your growth strategy in Oklahoma Shale and why is it potentially similar to the Bakken region?
A: Robert McIntosh, President & C.E.O.
Shale plays for oil and gas are the new technology of the industry. Advancements in direction drilling and secondary recovery allow us to drill along these shales - they have oil it's been found and is more of an engineering issue to extract it, like oil sands. So we will have known predictable oil and not have to "wildcat" hoping to discover oil. The Bakken is 200 feet thick and is worth billions to the companies involved. Our Oklahoma shale is new and we are on the cutting edge of drilling leasing and production. And the majors are there -- Devon, Chesapeake, Newfield and others now producing gas from the Woodford shale in the south of the State.
It is my opinion that the Woodford is a "mini-Bakken" for now and can possibly be one of the biggest oil plays in Oklahoma history.

Visit American Petro-Hunter, Inc. (OTC.BB:AAPH)
www.americanpetrohunter.com
Company Research
http://www.aaphreport.com/
Visit the AAPH showcase profile at InvestorIdeas.com
http://www.investorideas.com/CO/AAPH/
Contact American Petro-Hunter:
investors@americanpetrohunterinc.com
www.InvestorIdeas.com:
Sign up for free stock alerts, including AAPH and newsletters
http://www.investorideas.com/Resources/Newsletter.asp
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing.
The following news is paid for and/or published as information only for our readers. American Petro-Hunter, Inc. (OTC.BB:AAPH) one month showcase energy stock on InvestorIdeas.com and all related energy portals and blogs (twenty thousand per month).
InvestorIdeas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal. InvestorIdeas.com Disclaimer:
http://www.investorideas.com/About/Disclaimer.asp
InvestorIdeas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
For Additional Information about Investorideas.com energy portals:
800-665-0411 or cvanzant@investorideas.com

More Info:

Published at www.Investorideas.com - Global research by sectors

If you have any questions regarding information in this press release please contact the company listed in the press release.

Investorideas.com - NASDAQ Biotech Market Gainers; (NASDAQ:BPAX), (NASDAQ: CELG), (NASDAQ: GILD) Stocks to Watch

Investorideas.com - NASDAQ Biotech Market Gainers; (NASDAQ:BPAX), (NASDAQ: CELG), (NASDAQ: GILD) Stocks to Watch

NASDAQ Biotechnology Index Up

Point Roberts, WA –November 2, 2010 (Investorideas.com Newswire and www.biotechindustrystocks.com) - InvestorIdeas.com, a leader in sector research tools for investors, features a Biotech /Pharma Sector Trading Snapshot featuring some of the NASDAQ’s market gainers in today’s trading.. Gilead Sciences Inc. (NASDAQ: GILD is currently trading at $40.29, up 0.05 (0.10%) on over 3.5 million shares.

Biotech /Pharma Sector Trading Snapshot: (as of time of release November 2nd)

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) trading at $1.52, up 0.02 (1.33%)
Celgene Corporation (NASDAQ: CELG) trading at $62.95, up 1.05 (31.70%)
Gilead Sciences Inc. (NASDAQ: GILD) trading at $ 40.29, up 0.05 (0.10%) on over 3,511,673 million shares

NASDAQ Biotechnology Index
Index Value Net Change High Low
927.10 3.15+ 931.30 923.

Market Summary

Dow 11,201.59 +76.97 +0.69%
Nasdaq 2,529.10 +24.26 +0.97%
S&P 500 1,193.75 +9.37 +0.79%
10 Yr Bond(%) 2.5940% -0.0340
Oil 84.25 +1.30 +1.57%
Gold 1,355.80 +5.60 +0.41%


Biotech/Pharma Stocks Recent News;

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) Investor Fact Sheet update and News:
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) Reports Positive LibiGel® Data Monitoring Committee Recommendation
No safety issues observed, study to continue as per protocol without modifications

LINCOLNSHIRE, Ill. - October 25, 2010 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that the Phase III LibiGel (testosterone gel) cardiovascular and breast cancer safety study will continue without modifications and will continue to enroll new subjects as a result of the fourth unblinded review of adverse events and the first unblinded statistical analysis for sample-size determination by its independent Data Monitoring Committee (DMC). The review and statistical analysis were based on 2,500 subjects who have been enrolled in the study. LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is currently no FDA approved product.
Full news: http://www.investorideas.com/CO/BPAX/news/10252.asp


Full Media Kit at: http://www.biosantepharma.com/downloads/BioSante-Fact-Sheet.pdf

Financial Highlights
• At September 30, 2010, BioSante had approximately $36M in cash
• Monthly burn rate of approximately $3.5M

Investment Highlights
• Financial resources to implement plan
• Late stage pharmaceutical product portfolio with significant growth potential
• LibiGel in three ongoing Phase III safety and efficacy clinical studies
• Elestrin is FDA approved and marketed in the U.S.
• Proprietary cancer vaccines in Phase II clinical trials
• Focused growth strategy
• Management’s proven ability to gain FDA approval, implement plans and increase stockholder value

More news - Visit the BPAX showcase profile at Investorideas.com
http://www.investorideas.com/CO/BPAX/
Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com

Gilead Sciences Inc. (NASDAQ: GILD) News:
Viread® for Hepatitis B Maintains Antiviral Suppression with No Development of Resistance Through Four Years of Treatment
“Gilead Sciences, Inc. today announced new data from the open-label phase of two pivotal Phase III clinical trials (Studies 102 and 103) evaluating the four-year efficacy of Viread® (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B virus (HBV) infection. Significantly, no resistance to Viread emerged over 192 weeks of treatment, and 10.8 percent of patients receiving Viread in Study 103 (HBeAg-positive) for four years experienced surface, or “s”, antigen (HBsAg) loss, which is a marker of the resolution of chronic HBV infection. Additional data from these studies and from Study 106 show the durable antiviral efficacy of Viread among several key patient subpopulations, including patients with high baseline viral levels, individuals of Asian descent and treatment-experienced patients. These findings are being presented at the 61st annual meeting of the American Association for the Study of Liver Diseases (The Liver Meeting 2010) in Boston.”
Full Article: http://finance.yahoo.com/news/Viread-for-Hepatitis-B-bw-2871028130.html?x=0&.v=1

About Gilead Sciences, Inc:
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

Research other biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp

About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.

Sign up for free stock alerts on biotech stocks and other leading sectors!
http://www.investorideas.com/Resources/Newsletter.asp


About our Biotech investor portal:
www.BiotechIndustryStocks.com is a global meeting place for investors and industry following the biotech and pharma sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.

Disclaimer/disclosure : The following news is sponsored for by showcase stocks BPAX (three thousand per month BPAX) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal. This site is currently compensated by featured companies, news submissions and online advertising.
More info:
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com

Investorideas.com - Energy Stocks on the Rise; (OTCBB: AAPH), (NYSE: BP), (NYSE: XOM), AMEX OIL INDEX (^XOI) Trading Up

Investorideas.com - Energy Stocks on the Rise; (OTCBB: AAPH), (NYSE: BP), (NYSE: XOM), AMEX OIL INDEX (^XOI) Trading Up



BP (NYSE: BP) Returns to Profit in Third Quarter with Strong Operating Performance


Point Roberts WA - November 2, 2010 (Investorideas.com Energy Newswire) – www.Investorideas.com reports on energy stocks trading as prices rise.

Energy Stocks Trading Close-Up
AMEX OIL INDEX (^XOI) trading at 1,096.9606, up 14.2112 (1.31%)
Amex Natural Gas Index (^XNG) trading at 556.35, up 6.32 (1.15%)
American Petro-Hunter, Inc. (OTC.BB: AAPH) trading at 0.33, up 0.03 (10.00%)
BP p.l.c. Common Stock (NYSE: BP) trading at $41.42, up 0.65 (1.59%)
Exxon Mobil Corporation Common (NYSE: XOM) trading at $67.92, up 0.97 (1.45%)


Market Summary (at time of this release)
Dow 11,196.97 +72.35 +0.65%
NASDAQ 2,526.48 +21.64 +0.86%
S&P 500 1,192.90 +8.52 +0.72%
10 Yr Bond (%) 2.5920% -0.0360
Oil 83.83 +0.88 +1.06%


Recent Oil Stocks News:
American Petro-Hunter (OTCBB: AAPH) to Commence Fracture Stimulation Program at NOJ26 Well
No.1 Well Stabilizing With Increased Oilcut as Predicted
SCOTTSDALE, AZ - November 1, 2010 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB:AAPH) ("American Petro-Hunter" or the "Company") is pleased to announce that completion processes have been finalized and down hole fracture operations have commenced with the onset of commercial production anticipated shortly.
The operator has advised that fracture stimulation of the lower oil bearing shale formation will proceed today. The plan was developed based on the results of a core analysis of the 40 foot oil shale pay zone. The analysis identified that the shale should respond favorably to an engineered program well within industry norms for the prevalent conditions.
Full news: http://www.investorideas.com/CO/AAPH/news/11011.asp


BP p.l.c. Common Stock (NYSE: BP) News -
BP Returns to Profit in Third Quarter with Strong Operating Performance


Release date: 02 November 2010
BP announced today that a strong operating performance across the group helped it return to profit in the third quarter of 2010 despite an additional pre-tax charge of $7.7 billion in respect of the Gulf of Mexico spill.
Headline replacement cost profit for the third quarter was $1.8 billion, compared with a loss of $17.0 billion in the previous quarter and a profit of $5.0 billion in the third quarter of 2009.
On an underlying basis, after adjusting for non-operating items, third-quarter replacement cost profit was $5.5 billion, an increase of 18 per cent on the year-ago quarter.
"These results demonstrate that BP is well on track for recovery after the tragic accident on the Deepwater Horizon drilling rig and subsequent oil spill," commented group chief executive Bob Dudley. "We have made good progress during the quarter. This strong operating performance shows the determination of everyone at BP to move the company forward and rebuild confidence after the terrible events of the past six months.
Full news: BP p.l.c. Common Stock (NYSE: BP)


Research more energy stocks: The oil and gas stocks directory lists publicly traded stocks from multiple global stock exchanges including TSX, ASX, OTC, NASDAQ and NYSE.http://www.investorideas.com/OGSN/Stock_List.asp
Additional Energy Stocks directories:
Natural Gas Stocks Directoryhttp://www.investorideas.com/Companies/NaturalGas/Stock_List.asp
Renewable Energy Stocks Directoryhttp://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp


About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the hunt for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Company Researchhttp://www.aaphreport.com/


Visit the AAPH showcase profile at Investorideas.comhttp://www.investorideas.com/CO/AAPH/


Request News and Info on AAPHhttp://www.investorideas.com/Resources/Newsletter.aspDisclosure, Disclaimer/ AAPH is a paid for advertising client on Investorideas.com - see below.
Contact American Petro-Hunter:
Mountainview IR Services, Inc.1-888-521-7762investors@americanpetrohunterinc.com
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.


Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp


Disclaimer/ Disclosure: The following news is paid for and /or published as information only for our readers. American Petro-hunter Inc. (AAPH.OB) one month showcase energy stock on Investorideas.com and all related energy portals and blogs (twenty thousand per month)
Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal .This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
For Additional Information about Investorideas.com energy portals: 800-665-0411 or cvanzant@investorideas.com

Investorideas.com - Energy Stocks on the Rise; (OTCBB: AAPH), (NYSE: BP), (NYSE: XOM), AMEX OIL INDEX (^XOI) Trading Up

Investorideas.com - Energy Stocks on the Rise; (OTCBB: AAPH), (NYSE: BP), (NYSE: XOM), AMEX OIL INDEX (^XOI) Trading Up


BP (NYSE: BP) Returns to Profit in Third Quarter with Strong Operating Performance


Subscribe to Investor Ideas Newswire


Visit this company: www.aaphreport.com
Point Roberts WA - November 2, 2010 (Investorideas.com Energy Newswire) – www.Investorideas.com reports on energy stocks trading as prices rise.

Energy Stocks Trading Close-Up
AMEX OIL INDEX (^XOI) trading at 1,096.9606, up 14.2112 (1.31%)
Amex Natural Gas Index (^XNG) trading at 556.35, up 6.32 (1.15%)
American Petro-Hunter, Inc. (OTC.BB: AAPH) trading at 0.33, up 0.03 (10.00%)
BP p.l.c. Common Stock (NYSE: BP) trading at $41.42, up 0.65 (1.59%)
Exxon Mobil Corporation Common (NYSE: XOM) trading at $67.92, up 0.97 (1.45%)


Market Summary (at time of this release)
Dow 11,196.97 +72.35 +0.65%
NASDAQ 2,526.48 +21.64 +0.86%
S&P 500 1,192.90 +8.52 +0.72%
10 Yr Bond (%) 2.5920% -0.0360
Oil 83.83 +0.88 +1.06%


Recent Oil Stocks News:
American Petro-Hunter (OTCBB: AAPH) to Commence Fracture Stimulation Program at NOJ26 Well
No.1 Well Stabilizing With Increased Oilcut as Predicted
SCOTTSDALE, AZ - November 1, 2010 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB:AAPH) ("American Petro-Hunter" or the "Company") is pleased to announce that completion processes have been finalized and down hole fracture operations have commenced with the onset of commercial production anticipated shortly.
The operator has advised that fracture stimulation of the lower oil bearing shale formation will proceed today. The plan was developed based on the results of a core analysis of the 40 foot oil shale pay zone. The analysis identified that the shale should respond favorably to an engineered program well within industry norms for the prevalent conditions.
Full news: http://www.investorideas.com/CO/AAPH/news/11011.asp
BP p.l.c. Common Stock (NYSE: BP) News -
BP Returns to Profit in Third Quarter with Strong Operating Performance
Release date: 02 November 2010
BP announced today that a strong operating performance across the group helped it return to profit in the third quarter of 2010 despite an additional pre-tax charge of $7.7 billion in respect of the Gulf of Mexico spill.
Headline replacement cost profit for the third quarter was $1.8 billion, compared with a loss of $17.0 billion in the previous quarter and a profit of $5.0 billion in the third quarter of 2009.
On an underlying basis, after adjusting for non-operating items, third-quarter replacement cost profit was $5.5 billion, an increase of 18 per cent on the year-ago quarter.
"These results demonstrate that BP is well on track for recovery after the tragic accident on the Deepwater Horizon drilling rig and subsequent oil spill," commented group chief executive Bob Dudley. "We have made good progress during the quarter. This strong operating performance shows the determination of everyone at BP to move the company forward and rebuild confidence after the terrible events of the past six months.
Full news: BP p.l.c. Common Stock (NYSE: BP)
Research more energy stocks: The oil and gas stocks directory lists publicly traded stocks from multiple global stock exchanges including TSX, ASX, OTC, NASDAQ and NYSE.http://www.investorideas.com/OGSN/Stock_List.asp


Additional Energy Stocks directories:
Natural Gas Stocks Directoryhttp://www.investorideas.com/Companies/NaturalGas/Stock_List.asp
Renewable Energy Stocks Directoryhttp://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp


About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the hunt for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Company Researchhttp://www.aaphreport.com/
Visit the AAPH showcase profile at Investorideas.comhttp://www.investorideas.com/CO/AAPH/
Request News and Info on AAPHhttp://www.investorideas.com/Resources/Newsletter.aspDisclosure, Disclaimer/ AAPH is a paid for advertising client on Investorideas.com - see below.
Contact American Petro-Hunter:
Mountainview IR Services, Inc.1-888-521-7762investors@americanpetrohunterinc.com
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure: The following news is paid for and /or published as information only for our readers. American Petro-hunter Inc. (AAPH.OB) one month showcase energy stock on Investorideas.com and all related energy portals and blogs (twenty thousand per month)
Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal .This site is currently compensated by featured companies, news submissions and online advertising.


Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
For Additional Information about Investorideas.com energy portals: 800-665-0411 or cvanzant@investorideas.com



More Investorideas.com Oil and Gas Investor content : www.OilandGasStockNews.com an energy stocks investor portal within InvestorIdeas.com provides investor research, energy stocks and industry commentary from Karl Miller, stock news and energy links as well as a directory of public companies within the oil and gas sector. Investors can follow energy news by subscribing to the energy stocks newswire at: http://www.investorideas.com/RSS/feeds/Energy.xmlOil and gas stocks - become a showcase energy stock on www.investorideas.com and its energy portals and blogs for as little as $1000 month !

Investorideas.com - Consumer/ Retail Stocks; YesDTC (OTCBB: YESD.PK) Acquires WordSmart(R) Product Rights and Infomercial Hosted by Alex Trebek

Investorideas.com - Consumer/ Retail Stocks; YesDTC (OTCBB: YESD.PK) Acquires WordSmart(R) Product Rights and Infomercial Hosted by Alex Trebek

SAN FRANCISCO - November 1, 2010 (Investorideas.com newswire) – YesDTC Holdings, Inc. (OTCBB:YESD), a direct-to-consumer global distributor and marketer of consumer goods and products, announced today the Company has acquired the ongoing direct response television and radio marketing rights to the popular knowledge and vocabulary building product called WordSmart(R). Under the terms of the agreement, YesDTC will begin booking all associated revenues as of early November 2010, a benefit that is expected to add meaningfully to YesDTC's revenue stream going forward.

Mr. Alex Trebek, the host of the popular television quiz show "Jeopardy!" which represents the number two prime time television series currently in syndication averaging nine million viewers a day, also serves as the host of the WordSmart long form television infomercial and endorses the WordSmart product line. The "Jeopardy!" quiz show is known for testing intellect and knowledge recall and it is high respected among many viewers for its ability to challenge contestants in categories of higher learning. Since its 1984 syndication debut, "Jeopardy!" has been honored with 28 Daytime Emmy Awards, more than any other syndicated game show. Eleven Emmys have been awarded for Outstanding Game Show/Audience Participation and host Alex Trebek himself has won five Daytime Emmy Awards for Outstanding Game Show Host. Mr. Trebek's association with "Jeopardy!" makes him a highly visible and publicly recognized leader in the higher education, learning and greater intellect industry, making him an ideal figurehead to endorse the WordSmart product line.

"We are very excited to have acquired this extremely successful property and its association with Alex Trebek. The WordSmart infomercial and marketing campaign is a proven commodity that is currently generating very strong media efficiency ratios and millions of dollars in recurring high-margin revenues," commented Joseph Noel, CEO of YesDTC Holdings. "With the agreement now complete, we are planning a rapid and seamless integration of the WordSmart infomercial and related operations into YesDTC that will allow us to began booking substantial additional revenues almost immediately. We are estimating YesDTC will generate at least $12 million of revenue from this initiative alone over the next 12 months, with additional substantial revenues coming from our other marketing programs. Importantly, we were able to acquire this high quality revenue stream with zero dilution to our shareholders."

Mr. Noel continued, "At YesDTC, we are building an exciting portfolio of high quality product offerings that are expected to generate significant revenues and profits for our Company and our shareholders. WordSmart represents our third major product marketing initiative after SimplyMusicTM, for which the infomercial began airing in the second quarter and MediPendantTM, which began airing last week. Additionally, we are currently planning the launch of our first international marketing initiative for the PureSleep(R) device later this quarter with additional initiatives already in the pipeline for the first and second quarters of 2011."

The WordSmart product includes a comprehensive suite of computer and Internet-based knowledge and vocabulary building programs targeted at grade school through college level students and at adults seeking to improve their reading speed, reading comprehension and general knowledge. SAT/ACT test preparation has also been a very strong market for this product line, partly because of the money back guarantee that students, under certain conditions, will be able to improve their SAT scores by at least 200 points and ACT scores by at least four points. The WordSmart product is also guaranteed to increase GRE/GMAT scores by similar levels and, with only a minimum of 20 hours of use, to increase a child's English or reading grade by one full letter grade.

The WordSmart infomercial can be view at http://vimeo.com/16363930. Information on SimplyMusic can be viewed at www.simplymusic.com. The infomercial for MediPendant can be seen at www.medipendant.com. For information on PureSleep please visit www.PureSleep.com.

About YesDTC Holdings, Inc.
YesDTC Holdings, Inc. is a direct-to-consumer marketing company specializing in direct response television (DRTV), internet and retail marketing programs. The Company brings a unique set of skills to this market space. YesDTC combines both the creative talents and financial acumen needed to create a total package for direct-to-consumer marketing programs. Importantly, the Company also maintains a strategic partnership with Schulberg Media Works (SMW), a pioneering media production firm in the direct-to-consumer space with a highly acclaimed list of successful client campaigns and product infomercials. SMW's track record is impressive, with nearly $1.0 billion in revenues generated and a high profile list of industry awards and recognitions. Specifically, SMW campaigns include Tempur-Pedic, Guthy-Renker, Sony, 24-Hour Fitness, Rhino Records, HarperCollins and PureSleep, among many others. More information on YesDTC Holding can be found at www.yesdtc.com and additional information on Schulberg Media Works can be found at www.smw.tv.

Forward-Looking Statements
Certain statements in this press release may constitute "forward-looking statements" that involve risks and uncertainties. These include statements about our expectations, plans, objectives, assumptions or future events. You should not place undue reliance on these forward-looking statements. Information concerning factors that could cause our actual results to differ materially from these forward-looking statements can be found in our periodic reports filed with the Securities and Exchange Commission. We undertake no obligation to publicly release revisions to these forward-looking statements to reflect future events or circumstances or reflect the occurrence of unanticipated events.

Contact:
YesDTC Holdings, IncChristian Kirsebom(925) 247-6666

Contact Investorideas.comdvanzant@investorideas.com

Visit the YESD showcase profile at Investorideas.com:
http://www.investorideas.com/CO/YESD/

Request News and Info on YESD: http://www.investorideas.com/Resources/Newsletter.asp

Visit this company: www.yesdtc.com

Disclosure, Disclaimer/ YESD is a paid advertising client on Investorideas.com.
YESD: one time fee five thousand and thirty thousand in shares

About Investorideas.com: Investor Ideas the can change the world

Sign up for free stock alerts and news:
http://www.investorideas.com/Resources/Newsletter.asp

Published at www.Investorideas.com - Global research by sectors

If you have any questions regarding information in this press release please contact the company listed in the press release.

Connect with Investorideas.com - http://www.twitter.com/Investorideas Publish Your News - Send a release - http://www.investorideas.com/News-Upload/

Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.

Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

Investorideas.com - Consumer/ Retail Stocks; YesDTC (OTCBB: YESD.PK) 8K Filing: Company entered into a License Agreement with WordSmart Corporation

Investorideas.com - Consumer/ Retail Stocks; YesDTC (OTCBB: YESD.PK) 8K Filing: Company entered into a License Agreement with WordSmart Corporation

Alex Trebek to act as an endorser of the WordSmart product line as part of agreement

SAN FRANCISCO - October 29, 2010 (Investorideas.com newswire) – Investorideas.com, a leader in sector investor research reports on recent news and the 8K filing for retail and consumer stock YesDTC Holdings, Inc. (OTCBB: YESD.PK).

8K Filing Hi-Lites:

On October 18, 2010 (the “Effective Date”), the Company entered into a License Agreement with WordSmart Corporation (“WordSmart”) for the “WordSmart” Product Line (the “License Agreement”). Pursuant to the License Agreement:

· WordSmart granted the Company, among other things, (i) an exclusive limited license to market, distribute and sell the vocabulary building educational product known as WordSmart in the United States, Canada, United Kingdom, New Zealand, Australia, Ireland and South Africa markets and (ii) a non-exclusive right to manufacture the related products.

· The Company agreed to pay WordSmart royalties of 5% of Net Collected Sales (as defined in the License Agreement) plus additional royalties to pay for the services of Alex Trebek and other actors. Royalty payments are due quarterly.
· The Company agreed to make advance payments of $100,000 to WordSmart, which will be credited against future royalties. Of this $100,000, $25,000 was due upon signing and has been paid, and $50,000 is due 14 calendar days after the Effective Date. This $50,000 is fully refundable if WordSmart fails to amend in writing its services agreement, dated as of January 24, 2007, with Gargoyle Productions, pursuant to which Alex Trebek acts as an endorser of the WordSmart product line, for a period of no less than two years at a royalty rate that is at least as favorable as the current one. The remaining $25,000 non-refundable payment is due 60 days after the Effective Date or on such extended date as agreed to by the parties.

· If WordSmart fails to reacquire the services of Alex Trebek for a period of at least two years under terms and conditions acceptable to the Company within 60 days of the Effective Date, the Company may terminate the License Agreement in its entirety.

· The License Agreement has a term of one year, and may be renewed at the option of the Company, for up to 4 additional one year terms, subject to certain conditions including the receipt by WordSmart of at least $50,000 during each calendar quarter during the one year period immediately preceding the renewal term.

Link to 8K Filing:
Summary: http://us.biz.yahoo.com/e/101028/yesd.pk8-k.html
Full Filing: http://yahoo.brand.edgar-online.com/DisplayFiling.aspx?dcn=0001213900-10-004377


Recent News:

YesDTC (OTCBB: YESD.PK) Announces the Initial Airing of a New Infomercial for the MediPendant(TM) Medical Alarm

YesDTC Holdings, Inc. (OTCBB:YESD.PK), a direct-to-consumer global distributor and marketer of consumer goods and products, announced today the Company and its product partner, Medical Alarms Concepts Holding, Inc. (OTCBB:MDHI), will begin airing a new infomercial via direct response television (DRTV) for the innovative and technologically superior MediPendant(TM) medical alarm device. The airing of the infomercial marks the commencement of a new DRTV marketing campaign designed to target a wide reaching national audience.
Full News: http://www.investorideas.com/CO/YESD/news/10261.asp

About YesDTC Holdings, Inc.

YesDTC Holdings, Inc. is a direct-to-consumer marketing company specializing in direct response television (DRTV), internet and retail marketing programs. The Company brings a unique set of skills to this market space. YesDTC combines both the creative talents and financial acumen needed to create a total package for direct-to-consumer marketing programs. Importantly, the Company also maintains a strategic partnership with Schulberg Media Works (SMW), a pioneering media production firm in the direct-to-consumer space with a highly acclaimed list of successful client campaigns and product infomercials. SMW's track record is impressive, with nearly $1.0 billion in revenues generated and a high profile list of industry awards and recognitions. Specifically, SMW campaigns include Tempur-Pedic, Guthy-Renker, Sony, 24-Hour Fitness, Rhino Records, HarperCollins and PureSleep, among many others. More information on YesDTC Holding can be found at www.yesdtc.com and additional information on Schulberg Media Works can be found at www.smw.tv.



Contact:
YesDTC Holdings, Inc
Christian Kirsebom
(925) 247-6666

Contact Investorideas.com
dvanzant@investorideas.com

Visit the YESD showcase profile at Investorideas.com

http://www.investorideas.com/CO/YESD/

Request News and Info on YESD
Disclosure, Disclaimer/ YESD is a paid advertising client on Investorideas.com.
YESD: one time fee five thousand and thirty thousand in shares

About Investorideas.com
- Investor Ideas the can change the world
Sign up for free stock alerts and news:
http://www.investorideas.com/Resources/Newsletter.asp


Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.

Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics

Investorideas.com - Biotech /Pharma Market Movers; (NYSE:BSX), (NASDAQ:BPAX), (OTCBB: UVFT), (NASDAQ: CELG) Stocks to Watch

Investorideas.com - Biotech /Pharma Market Movers; (NYSE:BSX), (NASDAQ:BPAX), (OTCBB: UVFT), (NASDAQ: CELG) Stocks to Watch

Boston Scientific (NYSE:BSX) Agrees to Sell Neurovascular Business to Stryker; StockTrades Over 16 Millions Shares in Morning Trading

Point Roberts, WA –October 28, 2010 (Investorideas.com Newswire and www.biotechindustrystocks.com) - InvestorIdeas.com, a leader in sector research tools for investors, features a Biotech /Pharma Sector Trading Snapshot of Market Gainers for today’s trading.. Bullish trading in some of the stocks includes Boston Scientific Corporation. (NSYE: BSX), one of the top advancing stocks on the NYSE currently trading at 6.3220, up 0.0120 (0.19%) on over 16 million shares.

Biotech /Pharma Sector Trading Snapshot: (as of time of release October 28th)

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) trading at $1.54, up 0.01 (0.65%)

Boston Scientific Corporation. (NYSE:BSX) trading at $6.3220, up 0.0120 (0.19%)

UV Flu Technologies, Inc. (OTCBB: UVFT) trading at $0.31 on over 500,000 shares in volume

Celgene Corporation (NASDAQ: CELG) trading at $61.52, up 2.11 (3.55%)


Biotech/Pharma Stocks Recent News;

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) News:
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) Reports Positive LibiGel® Data Monitoring Committee Recommendation
No safety issues observed, study to continue as per protocol without modifications

LINCOLNSHIRE, Ill. - October 25, 2010 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that the Phase III LibiGel (testosterone gel) cardiovascular and breast cancer safety study will continue without modifications and will continue to enroll new subjects as a result of the fourth unblinded review of adverse events and the first unblinded statistical analysis for sample-size determination by its independent Data Monitoring Committee (DMC). The review and statistical analysis were based on 2,500 subjects who have been enrolled in the study. LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is currently no FDA approved product.
Full news: http://www.investorideas.com/CO/BPAX/news/10252.asp

More news - Visit the BPAX showcase profile at Investorideas.com
http://www.investorideas.com/CO/BPAX/
Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com


UV Flu Technologies, Inc., (OTCBB: UVFT) News
UV Flu Technologies (OTCBB: UVFT) Featured in MWMarketMovers.com Analyst Report; Carried in Wednesday's Wall Street Journal
Analyst Report by Michael Williams; Published in Wall Street Journal, October 27, 2010

New York, NY – October 26, 2010 (Investorideas.com Newswire) - Biotech News Update: A 12-page analyst report on UV Flu Technologies, Inc. (OTCBB: UVFT) will be carried by The Wall Street Journal as an advertising insert in the October 27th edition of the paper. The Wall Street Journal is published by Dow Jones, a world-class publisher of financial and business newspapers, newswires, indexes, magazines, and more. The report has been authored by Michael Williams Market Movers and can also be found online by visiting www.MWMarketMovers.com.
Full news: http://www.investorideas.com/CO/UVFT/news/10261.asp

More news - Visit the UVFT showcase on Investorideas.com
http://www.investorideas.com/CO/UVFT/
Disclosure, Disclaimer/ UVFT is a paid advertising client on Investorideas.com


Boston Scientific Corporation. (NYSE:BSX)

Recent News; Boston Scientific Agrees to Sell Neurovascular Business to Stryker

“Boston Scientific Corporation today announced the execution of a definitive agreement under which Stryker Corporation will acquire Boston Scientific's Neurovascular business. The purchase price is $1.5 billion, payable in cash, of which $1.4 billion is payable at closing and $100 million will be payable following the closing and upon the occurrence of the commercialization of the next-generation Target™ Detachable Coils and the transfer or separation of certain manufacturing facilities, which is anticipated to occur over a period of approximately 24 months. The Company expects to record a gain upon closing in excess of $500 million, excluding any impact of the receipt of future milestone payments. Total after-tax proceeds, assuming the achievement of these milestones, are expected to be approximately $1.2 billion. The Company expects to allocate approximately half of the net proceeds to acquisitions and the remainder to the retirement of pre-payable debt. The transaction is expected to close before the end of the year, subject to receipt of regulatory clearances and satisfaction of other customary conditions. As a result of the divestiture, the Company expects 2011 earnings per share to be diluted by approximately four to six cents on both a GAAP and adjusted basis.”
Full Article: http://finance.yahoo.com/news/Boston-Scientific-Agrees-to-prnews-3242744555.html?x=0&.v=1


About Boston Scientific Corporation. (NYSE:BSX): Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.

Research other biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp

About InvestorIdeas.com:

InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.

Sign up for free stock alerts on biotech stocks and other leading sectors!
http://www.investorideas.com/Resources/Newsletter.asp


About our Biotech investor portal:
www.BiotechIndustryStocks.com is a global meeting place for investors and industry following the biotech and pharma sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.

Disclaimer/disclosure : The following news is sponsored for by showcase stocks BPAX and UVFT ( third party on behalf of UV Flu- three thousand per month and three thousand per month BPAX) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com

Investorideas.com - OTCBB Trading Volume Leaders to Watch; (OTCB: CPMCF, CBIS, SGCA, CHTL)

Investorideas.com - OTCBB Trading Volume Leaders to Watch; (OTCB: CPMCF, CBIS, SGCA, CHTL)

Market Snapshot; Markets, Gold and Oil up

Note to Editors: The Following Is an Investment Opinion Being Issued by OTC VOLUME LEADERS

Point Roberts, WA (Investorideas.com Newswire) October 28 2010- OTC VOLUME LEADERS reports on the most recent actively trading stocks on the OTCBB for interested investors. OTC Volume leaders ($0.14-$0.25) include; Coastal Pacific Mining Corp. (CPMCF.OB), Cannabis Science, Inc. (CBIS.OB), Strategic American Oil Corporation (SGCA.OB) and
Strategic American Oil Corporation (SGCA.OB).

Leading sectors include Mining and oil and gas stocks.

More OTC stocks info:
Investors: Sign up at OTC Volume leaders and get access to info on hundreds of the most active OTCBB companies by clicking the sign up link below
http://bit.ly/otcvolumeleaders

MOST ACTIVE $0.14 - $0.25 - Top 10
1. CPMCF
2. CBIS
3. SGCA
4. CHTL
5. ADXS
6. SFMI
7. NXTH
8. IWEB
9. FEWP
10. BNTNF

Trading leader, - Coastal Pacific Mining Corp. (OTC.BB: CPMCF) News:

Coastal Pacific Provides Additional Santa Rita Property Details From 43-101 Report

CALGARY, AB--- 10/27/10 - Coastal Pacific Mining Corp. (OTC.BB:CPMCF) ("Coastal Pacific" or the "Company"), further to yesterday's announcement of a letter of intent in regards to the Santa Rita Property, situated in the District of Acobambilla, Province of Huancavelica, Department of Huancavelica, in the Republic of Peru ("Property"), the Company is providing additional information on the Property as obtained from a recent 43-101 report.
Full news:

Market Snapshot: (at time of this release) – Markets, Gold and Oil up

Dow 11,155.34 +29.06 +0.26%
NASDAQ 2,510.37 +7.11 +0.28%
S&P 500 1,187.23 +4.78 +0.40%
10 Yr Bond (%) 2.6780% -0.0340
Oil 82.47 +0.53 +0.65%
Gold 1,334.30 +12.10 +0.92%

More investor info :
OTCBB Investors: Register with us and start tracking OTC volume leaders and recent news.
And sign up for free our Newsletter http://bit.ly/otcvolumeleaders and get access to info on hundreds of the most active OTCBB companies and keep up to date with developments of the companies.
You can also subscribe to the RSS news feed: http://www.investorideas.com/CO/OTC/OTC-Volume-Leaders-NewsFeed.xml
Investors in British Columbia Canada: Do not subscribe to any OTC stocks not currently filing with Sedar in BC and BC Securities

OTC VOLUME LEADERS provides investors with daily market updates showcasing the most actively traded OTCBB Companies. We strive to provide you with the most up-to-date market information and activity by searching through hundreds of OTCBB companies in order to provide you information on the best of these companies. The goal is to continually find tomorrow’s market leading companies, today!

Disclosure: OTCVolumeleaders.com has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.
Investorideas.com acts as a third party publisher of content and is compensated for news release publishing (http://www.investorideas.com/About/Disclaimer.asp)

Please view the full OTC Volume Leader’s disclaimer: http://www.otcvolumeleaders.com/
Source http://www.otcvolumeleaders.com/

Follow OTC Volume Leaders on Twitter.com http://twitter.com/OTCVolumeLeader

For more info contact: http://www.otcvolumeleaders.com/

Investorideas.com - Direct to Consumer Medical/ Biotech Stocks; YesDTC (OTCBB: YESD.PK), GENEREX BIOTECH CORP (GNBT.PK), Utah Medical Products, Inc. (NASDAQ:UTMD)

Investorideas.com - Direct to Consumer Medical/ Biotech Stocks; YesDTC (OTCBB: YESD.PK), GENEREX BIOTECH CORP (GNBT.PK), Utah Medical Products, Inc. (NASDAQ:UTMD)

SAN FRANCISCO - October 27, 2010 (Investorideas.com newswire) – Investorideas.com, a leader in sector investor research including biotech and medical stocks, reports on recent news and developments from YesDTC (OTCBB: YESD.PK) and GENEREX BIOTECH CORP (GNBT.PK) and Utah Medical Products, Inc. (NASDAQ:UTMD).

Recent news:
YesDTC (OTCBB: YESD.PK) News:
YesDTC (OTCBB: YESD.PK) Announces the Initial Airing of a New Infomercial for the MediPendant(TM) Medical Alarm

YesDTC Holdings, Inc. (OTCBB:YESD.PK), a direct-to-consumer global distributor and marketer of consumer goods and products, announced today the Company and its product partner, Medical Alarms Concepts Holding, Inc. (OTCBB:MDHI), will begin airing a new infomercial via direct response television (DRTV) for the innovative and technologically superior MediPendant(TM) medical alarm device. The airing of the infomercial marks the commencement of a new DRTV marketing campaign designed to target a wide reaching national audience.
Full News: http://www.investorideas.com/CO/YESD/news/10261.asp


GENEREX BIOTECH CORP (GNBT.PK) News:
Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
GMD's expertise in governmental & insurer reimbursement expected to be a valuable asset for Generex's diabetes platform

WORCESTER, Mass., Oct. 11 /-- Generex Biotechnology Corporation (NasdaqCM: GNBT) (www.generex.com) today announced that it has entered into a definitive agreement to acquire a majority interest (51%) in Global Medical Direct, LLC ("GMD") of Lenexa, Kansas, a nationwide Durable Medical Equipment and Pharmaceutical provider specializing in direct-to-consumer diabetes supplies and medications (www.globalmeddirect.com).
Full news see company website.
Note Generex Biotechnology Corporation (NasdaqCM: GNBT) is now trading under stock symbol
(GNBT.PK).


Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2010

SALT LAKE CITY, Oct. 21, 2010 - Utah Medical Products, Inc. (Nasdaq:UTMD - News) reports lower sales, improved profit margins and a stronger ending balance sheet for the third calendar quarter (3Q) 2010 compared to 3Q 2009.
Full news : http://finance.yahoo.com/news/Utah-Medical-Products-Inc-pz-1621271546.html?x=0&.v=1
Utah Medical markets its products through direct sales representatives, independent manufacturers representatives, specialty distributors, national hospital distribution companies, and other medical device manufacturers in the United States; and through other medical device companies and independent medical products distributors internationally


About YesDTC Holdings, Inc.

YesDTC Holdings, Inc. is a direct-to-consumer marketing company specializing in direct response television (DRTV), internet and retail marketing programs. The Company brings a unique set of skills to this market space. YesDTC combines both the creative talents and financial acumen needed to create a total package for direct-to-consumer marketing programs. Importantly, the Company also maintains a strategic partnership with Schulberg Media Works (SMW), a pioneering media production firm in the direct-to-consumer space with a highly acclaimed list of successful client campaigns and product infomercials. SMW's track record is impressive, with nearly $1.0 billion in revenues generated and a high profile list of industry awards and recognitions. Specifically, SMW campaigns include Tempur-Pedic, Guthy-Renker, Sony, 24-Hour Fitness, Rhino Records, HarperCollins and PureSleep, among many others. More information on YesDTC Holding can be found at www.yesdtc.com and additional information on Schulberg Media Works can be found at www.smw.tv.



Contact:
YesDTC Holdings, Inc
Christian Kirsebom
(925) 247-6666

Contact Investorideas.com
dvanzant@investorideas.com

Visit the YESD showcase profile at Investorideas.com

http://www.investorideas.com/CO/YESD/

Request News and Info on YESD
Disclosure, Disclaimer/ YESD is a paid advertising client on Investorideas.com.
YESD: one time fee five thousand and thirty thousand in shares

About Investorideas.com
- Investor Ideas the can change the world
Sign up for free stock alerts and news:
http://www.investorideas.com/Resources/Newsletter.asp


Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.

Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics
Investor Protection and Regulation for Pinks sheets: http://www.pinksheets.com/otcguide/investors_protection.jsp

Investorideas.com - Biotech/Pharma Sector Trading Snapshot; (NASDAQ: BPAX), (NASDAQ: CADX), (NASDAQ:SUPG), (OTCBB: UVFT)

Investorideas.com - Biotech/Pharma Sector Trading Snapshot; (NASDAQ: BPAX), (NASDAQ: CADX), (NASDAQ:SUPG), (OTCBB: UVFT)

Point Roberts, WA –October 27, 2010 (Investorideas.com Newswire and www.biotechindustrystocks.com) - InvestorIdeas.com, a leader in sector research tools for investors, features a Biotech /Pharma Sector Trading Snapshot, as of the close October 26th. Bullish trading in some of the stocks included SuperGen, Inc.(NasdaqGM: SUPG), one of the top advancing stocks on the NASDAQ, closing at $2.82, up $ 0.49 (21.03%), followed by additional gains in after market trading.

Biotech /Pharma Sector Trading Snapshot: (as of close October 26th)

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) closed at $1.57, up 0.01 (0.64%), trading as high as $1.59 on the day.
Cadence Pharmaceuticals Inc. (NASDAQ: CADX) closed at $8.9, up 0.24 (2.75%) on 445,648 shares.
SuperGen Inc. (NASDAQ:SUPG) closed at $2.82, up $ 0.49 (21.03%) on over 3.4 million shares.
UV Flu Technologies, Inc. (OTCBB: UVFT) closed at $0.3850, up 0.0250 (6.94%) on over 1.3 million shares.

Biotech/Pharma Stocks Recent News;

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) News:
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) Reports Positive LibiGel® Data Monitoring Committee Recommendation
No safety issues observed, study to continue as per protocol without modifications

LINCOLNSHIRE, Ill. - October 25, 2010 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that the Phase III LibiGel (testosterone gel) cardiovascular and breast cancer safety study will continue without modifications and will continue to enroll new subjects as a result of the fourth unblinded review of adverse events and the first unblinded statistical analysis for sample-size determination by its independent Data Monitoring Committee (DMC). The review and statistical analysis were based on 2,500 subjects who have been enrolled in the study. LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is currently no FDA approved product.
Full news: http://www.investorideas.com/CO/BPAX/news/10252.asp

More news - Visit the BPAX showcase profile at Investorideas.com
http://www.investorideas.com/CO/BPAX/
Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com


UV Flu Technologies, Inc., (OTCBB: UVFT) News
UV Flu Technologies (OTCBB: UVFT) Featured in MWMarketMovers.com Analyst Report; Carried in Wednesday's Wall Street Journal
Analyst Report by Michael Williams; Published in Wall Street Journal, October 27, 2010

New York, NY – October 26, 2010 (Investorideas.com Newswire) - Biotech News Update: A 12-page analyst report on UV Flu Technologies, Inc. (OTCBB: UVFT) will be carried by The Wall Street Journal as an advertising insert in the October 27th edition of the paper. The Wall Street Journal is published by Dow Jones, a world-class publisher of financial and business newspapers, newswires, indexes, magazines, and more. The report has been authored by Michael Williams Market Movers and can also be found online by visiting www.MWMarketMovers.com.
Full news: http://www.investorideas.com/CO/UVFT/news/10261.asp

More news - Visit the UVFT showcase on Investorideas.com
http://www.investorideas.com/CO/UVFT/
Disclosure, Disclaimer/ UVFT is a paid advertising client on Investorideas.com

SuperGen, Inc. (NASDAQ:SUPG) News:

SuperGen Reports 2010 Third Quarter Financial Results
Dacogen Royalty Revenue Increases 28% from Same Prior Year Quarter Increases Annual Royalty and Net Income Guidance for 2010

DUBLIN, Calif.—October 25, 2010 - SuperGen, Inc. (NASDAQ:SUPG ) today reported financial results for the third quarter and nine months ended September 30, 2010.
“The third quarter was another profitable one for SuperGen. Royalties from Dacogen sales increased significantly, and we ended the quarter with more than $112 million in unrestricted cash, cash equivalents and current and non-current marketable securities, and no debt. As a result, we have raised both our royalty revenue and net income guidance for 2010,” said James S.J. Manuso, Ph.D., President and CEO. “We continue to advance the development of our drugs in the clinic, and SGI-110, a novel, second-generation DNA methylation inhibitor, is on schedule to enter a first-in-human clinical trial in myelodysplastic syndromes and AML during November.”
Full News; http://finance.yahoo.com/news/SuperGen-Reports-2010-Third-bw-1951926175.html?x=0&.v=1

Research other biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp

About InvestorIdeas.com:

InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.

Sign up for free stock alerts on biotech stocks and other leading sectors!
http://www.investorideas.com/Resources/Newsletter.asp


About our Biotech investor portal:
www.BiotechIndustryStocks.com is a global meeting place for investors and industry following the biotech and pharma sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.

Disclaimer/disclosure : The following news is sponsored for by showcase stocks BPAX and UVFT ( third party on behalf of UV Flu- three thousand per month and three thousand per month BPAX) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal. This site is currently compensated by featured companies, news submissions and online advertising.
More info:
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com

Investorideas.com - Consumer/ Retail Stocks News; YesDTC (OTCBB: YESD.PK) Announces New Infomercial for the MediPendant(TM) Medical Alarm

Investorideas.com - Consumer/ Retail Stocks News; YesDTC (OTCBB: YESD.PK) Announces New Infomercial for the MediPendant(TM) Medical Alarm


Visit this company: www.yesdtc.com


SAN FRANCISCO - October 27, 2010 (Investorideas.com newswire) - YesDTC Holdings, Inc. (OTCBB:YESD.PK), a direct-to-consumer global distributor and marketer of consumer goods and products, announced today the Company will officially begin airing its new infomercial for the MediPendant(TM) personal medial alarm, by Medical Alarm Concepts Holding, Inc. (OTCBB:MDHI), beginning today on six national cable stations in addition to local broadcast stations.

The new infomercial for MediPendant(TM) is sponsored by YesDTC and is set to start airing on Wednesday October 27th on the Discovery Health channel. It will continue to run throughout the week at various times on multiple national cable stations including Discovery Health, ESPN News, Inspiration, Lifetime Movie, Tru TV and TV Land as well as on local broadcast stations such as Northwest Cable News, until the end of the month.

Following the successful conclusion of this test market run, YesDTC plans to expand programming of the infomercial nationwide in a full rollout of the MediPendant(TM) marketing campaign. The campaign will target a wide audience of viewers in the 30 to 55 year age range who have elderly parents or loved ones that could benefit from the safety and assurance the MediPendant(TM) device can provide, including access to medical and emergency response personnel and/or personal contacts within the device user's network of friends and family.

The MediPendant(TM) infomercial can also be viewed by clicking on the following link: http://vimeo.com/16188152.

About the MediPendant(TM) Personal Alarm Device

Medical Alarm Concepts(TM) offers a unique, patented, medical emergency alarm system that is different from all other personal emergency response (PERS) systems on the market today. MDHI's MediPendant(TM) product offers several revolutionary and highly desirable features, including the ability to speak and listen to the operator directly through the pendant, an extended range of mobility from the base station, which enables the user to move virtually anywhere in or around their home, and a call center staffed around the clock with EMT-certified operators. Specifically, the MediPendant(TM) system enables the device wearer to move up to 600+ feet away from the main base station, a distance that far exceeds competitive offerings on the market today that instead require the user to be within speaking distance of the base station box, a situation that may not be conducive to an emergency if the end user is not near the base station.

Additionally, MediPendant's(TM) advanced call center technology allows for three-way calling between the operator, the user, and the dispatched first responders and/or a friend and family member. Currently, no other available PERS systems offer the benefit of three-way voice conferencing directly through the pendant. Finally, EMT-certified operators are guaranteed to stay on the line with the MediPendant(TM) user until the problem is resolved or help arrives.

About YesDTC Holdings, Inc.

YesDTC Holdings, Inc. is a direct-to-consumer marketing company specializing in direct response television (DRTV), internet and retail marketing programs. The Company brings a unique set of skills to this market space. YesDTC combines both the creative talents and financial acumen needed to create a total package for direct-to-consumer marketing programs. Importantly, the Company also maintains a strategic partnership with Schulberg Media Works (SMW), a pioneering media production firm in the direct-to-consumer space with a highly acclaimed list of successful client campaigns and product infomercials. SMW's track record is impressive, with nearly $1.0 billion in revenues generated and a high profile list of industry awards and recognitions. Specifically, SMW campaigns include Tempur-Pedic, Guthy-Renker, Sony, 24-Hour Fitness, Rhino Records, HarperCollins and PureSleep, among many others. More information on YesDTC Holding can be found at www.yesdtc.com and additional information on Schulberg Media Works can be found at www.smw.tv.

Forward-Looking Statements

Certain statements in this press release may constitute "forward-looking statements" that involve risks and uncertainties. These include statements about our expectations, plans, objectives, assumptions or future events. You should not place undue reliance on these forward-looking statements. Information concerning factors that could cause our actual results to differ materially from these forward-looking statements can be found in our periodic reports filed with the Securities and Exchange Commission. We undertake no obligation to publicly release revisions to these forward-looking statements to reflect future events or circumstances or reflect the occurrence of unanticipated events.

Contact:

YesDTC Holdings, Inc
Christian Kirsebom
(925) 247-6666

Visit the YESD showcase profile at Investorideas.com
Request News and Info on YESD
Disclosure, Disclaimer/ YESD is a paid advertising client on Investorideas.com.
YESD: one time fee five thousand and thirty thousand in shares

More Info:

Published at www.Investorideas.com - Global research by sectors

If you have any questions regarding information in this press release please contact the company listed in the press release.

Connect with Investorideas.com




Publish Your News - Send a release

Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.

Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

Investorideas.com - Retails Stocks; YesDTC (OTCBB: YESD.PK) and Product Partner, (OTCBB: MDHI), Begin airing new Infomercial via Direct Response Television (DRTV)

Investorideas.com - Retails Stocks; YesDTC (OTCBB: YESD.PK) and Product Partner, (OTCBB: MDHI), Begin airing new Infomercial via Direct Response Television (DRTV)

New Infomercial Features the MediPendant(TM) Medical Alarm

Visit this company: www.yesdtc.com

SAN FRANCISCO - October 26, 2010 (Investorideas.com newswire) - Retail stock news YesDTC Holdings, Inc. (OTCBB:YESD.PK), a direct-to-consumer global distributor and marketer of consumer goods and products, reports the Company and its product partner, Medical Alarms Concepts Holding, Inc. (OTCBB:MDHI), will begin airing a new infomercial via direct response television (DRTV) for the innovative and technologically superior MediPendant(TM) medical alarm device. The airing of the infomercial marks the commencement of a new DRTV marketing campaign designed to target a wide reaching national audience.

Medical Alarms Concepts is the maker of the MediPendant(TM) product, a unique, patented medical emergency alert system that enables several revolutionary and highly desirable features including direct through-the-pendant speak-and-listen capabilities, the ability to conference in third party contacts and an extended product operating range that allows users to significantly extend their mobility away from the home base station unit.

Programming is scheduled to begin the week of October 24th and is being sponsored by YesDTC, which is funding the campaign. The infomercial targets both male and female demographics in the age range of 30 to 55 years who have elderly parents or loved ones that could benefit from the safety and assurance the MediPendant(TM) device can provide, including access to medical and emergency response personnel and/or personal contacts within the device user's network of friends and family. In order to reach this audience, the MediPendant(TM) infomercial will be aired on the following stations: Discovery Health, ESPN News, Inspiration, Lifetime Movie, Northwest Cable News, Tru TV and TV Land.

Joseph Noel, CEO of YesDTC Holding, Inc., commented, "We are very excited to be launching this much anticipated infomercial featuring the MediPendant(TM) by Medical Alarms Concepts. The personal medical alarm market and emergency medical communications device market are a proven product category that receives a lot of interest among consumers, representing tens of millions of dollars per year. We believe MediPendant(TM) has all the right new features to see someone effectively through an emergency situation and is a technology superior offering compared to other such standard devices available on the market today." Mr. Noel continued, "With a proven market and superior product, we are confident we can penetrate this industry as a formidable player and we are already planning to ramp-up our media spending once initial airing of the infomercial is complete in the near term."

About the MediPendant(TM) Personal Alarm Device

Medical Alarm Concepts(TM) offers a unique, patented, medical emergency alarm system that is different from all other personal emergency response (PERS) systems on the market today. MDHI's MediPendant(TM) product offers several revolutionary and highly desirable features, including the ability to speak and listen to the operator directly through the pendant, an extended range of mobility from the base station, which enables the user to move virtually anywhere in or around their home, and a call center staffed around the clock with EMT-certified operators. Specifically, the MediPendant(TM) system enables the device wearer to move up to 600+ feet away from the main base station, a distance that far exceeds competitive offerings on the market today that instead require the user to be within speaking distance of the base station box, a situation that may not be conducive to an emergency if the end user is not near the base station.

Additionally, MediPendant's(TM) advanced call center technology allows for three-way calling between the operator, the user, and the dispatched first responders and/or a friend and family member. Currently, no other available PERS systems offer the benefit of three-way voice conferencing directly through the pendant. Finally, EMT-certified operators are guaranteed to stay on the line with the MediPendant(TM) user until the problem is resolved or help arrives.

About YesDTC Holdings, Inc.

YesDTC Holdings, Inc. is a direct-to-consumer marketing company specializing in direct response television (DRTV), internet and retail marketing programs. The Company brings a unique set of skills to this market space. YesDTC combines both the creative talents and financial acumen needed to create a total package for direct-to-consumer marketing programs. Importantly, the Company also maintains a strategic partnership with Schulberg Media Works (SMW), a pioneering media production firm in the direct-to-consumer space with a highly acclaimed list of successful client campaigns and product infomercials. SMW's track record is impressive, with nearly $1.0 billion in revenues generated and a high profile list of industry awards and recognitions. Specifically, SMW campaigns include Tempur-Pedic, Guthy-Renker, Sony, 24-Hour Fitness, Rhino Records, HarperCollins and PureSleep, among many others. More information on YesDTC Holding can be found at www.yesdtc.com and additional information on Schulberg Media Works can be found at www.smw.tv.

Forward-Looking Statements

Certain statements in this press release may constitute "forward-looking statements" that involve risks and uncertainties. These include statements about our expectations, plans, objectives, assumptions or future events. You should not place undue reliance on these forward-looking statements. Information concerning factors that could cause our actual results to differ materially from these forward-looking statements can be found in our periodic reports filed with the Securities and Exchange Commission. We undertake no obligation to publicly release revisions to these forward-looking statements to reflect future events or circumstances or reflect the occurrence of unanticipated events.

Contact:

YesDTC Holdings, Inc
Christian Kirsebom
(925) 247-6666

Visit the YESD showcase profile at Investorideas.com
http://www.investorideas.com/CO/YESD/
Request News and Info on YESD
Disclosure, Disclaimer/ YESD is a paid advertising client on Investorideas.com YESD: one time fee five thousand and thirty thousand in shares
Investor Protection and Regulation for Pinks sheets: http://www.pinksheets.com/otcguide/investors_protection.jsp

Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.

Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp